Minal R Patel1, Peter X K Song2, Georgiana Sanders3, Belinda Nelson4, Elena Kaltsas4, Lara J Thomas4, Mary R Janevic4, Kausar Hafeez4, Wen Wang2, Margaret Wilkin4, Timothy R Johnson5, Randall W Brown4. 1. Department of Health Behavior and Health Education, University of Michigan, Ann Arbor, Michigan. Electronic address: minalrp@umich.edu. 2. Department of Biostatistics, University of Michigan, Ann Arbor, Michigan. 3. Department Allergy and Immunology, University of Michigan, Ann Arbor, Michigan. 4. Department of Health Behavior and Health Education, University of Michigan, Ann Arbor, Michigan. 5. Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan.
Abstract
BACKGROUND: Few interventions have focused on the difficulties that African American women face when managing asthma. OBJECTIVE: To evaluate a telephone-based self-regulation intervention that emphasized African American women's management of asthma in a series of 6 sessions. METHODS: A total of 422 African American women with persistent asthma were randomly assigned to either an intervention or control group receiving usual care. Behavioral factors, symptoms and asthma control, asthma-related quality of life, and health care use at baseline and 2 years after baseline were assessed. Generalized estimating equations were used to assess the long-term effect of the intervention on outcomes. RESULTS: Compared with the control group, those who completed the full intervention (6 sessions) had significant gains in self-regulation of their asthma (B estimate, 0.73; 95% CI, 0.17-1.30; P < .01), noticing changes to their asthma during their menstrual cycle (B estimate, 1.42; 95% CI, 0.69-2.15; P < .001), and when having premenstrual syndrome (B estimate, 1.70; 95% CI, 0.67-2.72; P < .001). They also had significant reductions in daytime symptoms (B estimate, -0.15; 95% CI, -0.27 to -0.03; P < .01), asthma-related hospitalization (B estimate, 0.51; 95% CI, 0.00-1.02; P < .05), and improved asthma control (B estimate, 1.34; 95% CI, 0.57-2.12; P < .001). However, neither grouped changed over time in outcomes. CONCLUSION: Despite high comorbidity, African American women who completed a culturally responsive self-management program had improvements in asthma outcomes compared with the control group. Future work should address significant comorbidities and psychosocial issues alongside asthma management to improve asthma outcomes in the long term. TRIAL REGISTRATION: clinicaltrials.gov Identifier NCT01117805.
RCT Entities:
BACKGROUND: Few interventions have focused on the difficulties that African American women face when managing asthma. OBJECTIVE: To evaluate a telephone-based self-regulation intervention that emphasized African American women's management of asthma in a series of 6 sessions. METHODS: A total of 422 African American women with persistent asthma were randomly assigned to either an intervention or control group receiving usual care. Behavioral factors, symptoms and asthma control, asthma-related quality of life, and health care use at baseline and 2 years after baseline were assessed. Generalized estimating equations were used to assess the long-term effect of the intervention on outcomes. RESULTS: Compared with the control group, those who completed the full intervention (6 sessions) had significant gains in self-regulation of their asthma (B estimate, 0.73; 95% CI, 0.17-1.30; P < .01), noticing changes to their asthma during their menstrual cycle (B estimate, 1.42; 95% CI, 0.69-2.15; P < .001), and when having premenstrual syndrome (B estimate, 1.70; 95% CI, 0.67-2.72; P < .001). They also had significant reductions in daytime symptoms (B estimate, -0.15; 95% CI, -0.27 to -0.03; P < .01), asthma-related hospitalization (B estimate, 0.51; 95% CI, 0.00-1.02; P < .05), and improved asthma control (B estimate, 1.34; 95% CI, 0.57-2.12; P < .001). However, neither grouped changed over time in outcomes. CONCLUSION: Despite high comorbidity, African American women who completed a culturally responsive self-management program had improvements in asthma outcomes compared with the control group. Future work should address significant comorbidities and psychosocial issues alongside asthma management to improve asthma outcomes in the long term. TRIAL REGISTRATION: clinicaltrials.gov Identifier NCT01117805.
Authors: Giorgio Ciprandi; Irene Schiavetti; Elena Rindone; Fabio L M Ricciardolo Journal: Ann Allergy Asthma Immunol Date: 2015-09-29 Impact factor: 6.347
Authors: Wendy Gould; Edward L Peterson; Gloria Karungi; Amanda Zoratti; John Gaggin; Ghazwan Toma; Shiqing Yan; Albert M Levin; James J Yang; Karen Wells; Mingqun Wang; Robert R Burke; Kenneth Beckman; Danijela Popadic; Susan J Land; Rajesh Kumar; Max A Seibold; David E Lanfear; Esteban G Burchard; L Keoki Williams Journal: J Allergy Clin Immunol Date: 2010-12 Impact factor: 10.793
Authors: Michael D Cabana; Kathryn K Slish; David Evans; Robert B Mellins; Randall W Brown; Xihong Lin; Niko Kaciroti; Noreen M Clark Journal: Pediatrics Date: 2006-06 Impact factor: 7.124
Authors: Max A Seibold; Bin Wang; Celeste Eng; Gunjan Kumar; Kenneth B Beckman; Saunak Sen; Shweta Choudhry; Kelley Meade; Michael Lenoir; H Geoffrey Watson; Shannon Thyne; L Keoki Williams; Rajesh Kumar; Kevin B Weiss; Leslie C Grammer; Pedro C Avila; Robert P Schleimer; Esteban González Burchard; Robert Brenner Journal: Hum Mol Genet Date: 2008-06-04 Impact factor: 6.150
Authors: Karen M Goldstein; Leah L Zullig; Eric A Dedert; Amir Alishahi Tabriz; Timothy W Brearly; Giselle Raitz; Suchita Shah Sata; John D Whited; Hayden B Bosworth; Adelaide M Gordon; Avishek Nagi; John W Williams; Jennifer M Gierisch Journal: J Gen Intern Med Date: 2018-10-03 Impact factor: 6.473